Related Experiment Video
Updated: Feb 27, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression
Qinggang Dai1,2, Zhan Xu2, Xuhui Ma3
1Department of Pediatric Dentistry, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University; Shanghai Key Laboratory of Stomatology, Shanghai 200011, China.
Abstract:
The mammalian target of rapamycin (mTOR)/regulatory-associated protein of mTOR (Raptor) pathway transmits and integrates different signals including growth factors, nutrients, and energy metabolism. Nearly all these signals have been found to play roles in skeletal biology. However, the contribution of mTOR/Raptor to osteoblast biology in vivo remains to be elucidated as the conclusions of recent studies are controversial. Here we report that mice with a deficiency of either mTOR or Raptor in preosteoblasts exhibited clavicular hypoplasia and delayed fontanelle fusion, similar to those found in human patients with cleidocranial dysplasia (CCD) haploinsufficient for the transcription factor runt-related transcription factor 2 (Runx2) or those identified in Runx2+/- mice. Mechanistic analysis revealed that the mTOR-Raptor-S6K1 axis regulates Runx2 expression through phosphorylation of estrogen receptor α, which binds to Distal-less homeobox 5 (DLX5) and augments the activity of Runx2 enhancer. Moreover, heterozygous mutation of raptor in osteoblasts aggravates the bone defects observed in Runx2+/- mice, indicating a genetic interaction between Raptor and Runx2. Collectively, these findings reveal that mTOR/Raptor signaling is essential for bone formation in vivo through the regulation of Runx2 expression. These results also suggest that a selective mTOR/Raptor antagonist, which has been developed for treatment of many diseases, may have the side effect of causing bone loss.
Insights
The mammalian target of rapamycin (mTOR)/regulatory-associated protein of mTOR (Raptor) pathway is crucial for bone formation. mTOR/Raptor signaling regulates runt-related transcription factor 2 (Runx2) expression, impacting skeletal development.
Area of Science:
- Molecular Biology
- Skeletal Biology
- Cell Signaling
Background:
- The mammalian target of rapamycin (mTOR)/regulatory-associated protein of mTOR (Raptor) pathway integrates growth factors, nutrients, and energy metabolism signals.
- These signals are known to influence skeletal biology, but the specific role of mTOR/Raptor in osteoblast biology in vivo is debated.
Purpose of the Study:
- To elucidate the in vivo role of the mTOR/Raptor pathway in osteoblast biology.
- To investigate the molecular mechanisms by which mTOR/Raptor signaling affects bone formation.
Main Methods:
- Generation of mice with deficiencies in mTOR or Raptor in preosteoblasts.
- Analysis of skeletal phenotypes, including clavicular hypoplasia and fontanelle fusion.
- Mechanistic studies involving estrogen receptor α (ERα), Distal-less homeobox 5 (DLX5), and runt-related transcription factor 2 (Runx2) expression and activity.
Main Results:
- Mice lacking mTOR or Raptor in preosteoblasts displayed clavicular hypoplasia and delayed fontanelle fusion, mimicking cleidocranial dysplasia (CCD).
- The mTOR-Raptor-S6K1 axis was found to regulate Runx2 expression via ERα phosphorylation, influencing Runx2 enhancer activity.
- Genetic interaction between Raptor and Runx2 was observed, with Raptor deficiency exacerbating bone defects in Runx2+/- mice.
Conclusions:
- mTOR/Raptor signaling is essential for in vivo bone formation by regulating Runx2 expression.
- These findings highlight a critical role for mTOR/Raptor in skeletal development.
- Selective mTOR/Raptor antagonists might pose a risk of bone loss as a side effect.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Determination
MAPK Signaling Cascades
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

